 Kristine Kuhn
Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spondylarthritis | 16 | 2025 | 50 | 6.720 |
Why?
| | Gastrointestinal Microbiome | 18 | 2025 | 773 | 4.190 |
Why?
| | Arthritis, Rheumatoid | 21 | 2025 | 1183 | 4.160 |
Why?
| | Microbiota | 13 | 2025 | 736 | 3.660 |
Why?
| | Spondylitis, Ankylosing | 6 | 2022 | 43 | 2.790 |
Why?
| | Arthritis, Experimental | 8 | 2025 | 136 | 2.740 |
Why?
| | Immunity, Mucosal | 7 | 2025 | 98 | 2.020 |
Why?
| | Intraepithelial Lymphocytes | 3 | 2024 | 17 | 1.880 |
Why?
| | Inflammatory Bowel Diseases | 11 | 2025 | 366 | 1.870 |
Why?
| | Intestinal Mucosa | 8 | 2025 | 676 | 1.810 |
Why?
| | Dysbiosis | 5 | 2025 | 188 | 1.580 |
Why?
| | Intestines | 5 | 2021 | 356 | 1.570 |
Why?
| | Crohn Disease | 5 | 2025 | 262 | 1.550 |
Why?
| | Interleukin-17 | 3 | 2023 | 123 | 1.480 |
Why?
| | Colon | 5 | 2025 | 310 | 1.420 |
Why?
| | Arthritis | 4 | 2022 | 97 | 1.380 |
Why?
| | Inflammation | 12 | 2025 | 2920 | 1.050 |
Why?
| | Autoimmune Diseases | 4 | 2024 | 471 | 1.040 |
Why?
| | Rheumatology | 3 | 2024 | 136 | 1.020 |
Why?
| | Th17 Cells | 3 | 2025 | 103 | 1.000 |
Why?
| | Bacteria | 4 | 2025 | 769 | 0.970 |
Why?
| | Autoantibodies | 7 | 2025 | 1513 | 0.910 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2024 | 119 | 0.890 |
Why?
| | Pentanols | 1 | 2024 | 6 | 0.850 |
Why?
| | Butyrates | 2 | 2024 | 66 | 0.840 |
Why?
| | Lyases | 1 | 2024 | 15 | 0.830 |
Why?
| | Arthritis, Juvenile | 1 | 2025 | 64 | 0.830 |
Why?
| | Sphingosine | 1 | 2024 | 47 | 0.810 |
Why?
| | T-Lymphocytes | 4 | 2025 | 2017 | 0.800 |
Why?
| | Lysophospholipids | 1 | 2024 | 80 | 0.790 |
Why?
| | Tryptophan | 2 | 2023 | 183 | 0.780 |
Why?
| | Myeloid Cells | 1 | 2024 | 150 | 0.750 |
Why?
| | Musculoskeletal Diseases | 1 | 2024 | 94 | 0.750 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 334 | 0.730 |
Why?
| | Interleukin-6 | 3 | 2017 | 784 | 0.700 |
Why?
| | Animals | 32 | 2025 | 38410 | 0.700 |
Why?
| | Immunoglobulin A | 1 | 2022 | 214 | 0.670 |
Why?
| | Mice | 24 | 2025 | 18491 | 0.650 |
Why?
| | Mice, Knockout | 3 | 2025 | 3153 | 0.600 |
Why?
| | Metagenomics | 1 | 2021 | 151 | 0.600 |
Why?
| | Mentoring | 1 | 2022 | 166 | 0.600 |
Why?
| | Biomedical Research | 2 | 2024 | 723 | 0.600 |
Why?
| | Metabolomics | 3 | 2025 | 736 | 0.590 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.520 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 6 | 0.520 |
Why?
| | Humans | 58 | 2025 | 147293 | 0.520 |
Why?
| | Osteoarthritis | 1 | 2020 | 204 | 0.510 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 43 | 0.500 |
Why?
| | Skin | 2 | 2020 | 759 | 0.450 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 204 | 0.440 |
Why?
| | Disease Models, Animal | 10 | 2025 | 4604 | 0.430 |
Why?
| | Collagen Type II | 2 | 2018 | 53 | 0.410 |
Why?
| | Collagen | 4 | 2023 | 460 | 0.390 |
Why?
| | Cytokines | 7 | 2025 | 2086 | 0.370 |
Why?
| | Anti-Citrullinated Protein Antibodies | 3 | 2024 | 129 | 0.350 |
Why?
| | Colitis | 3 | 2025 | 282 | 0.350 |
Why?
| | Antirheumatic Agents | 2 | 2024 | 308 | 0.330 |
Why?
| | Antigens | 2 | 2013 | 348 | 0.320 |
Why?
| | Receptors, Complement 3d | 2 | 2008 | 136 | 0.310 |
Why?
| | RNA, Ribosomal, 16S | 4 | 2025 | 512 | 0.300 |
Why?
| | Mice, Inbred DBA | 4 | 2024 | 182 | 0.290 |
Why?
| | Immunity, Innate | 3 | 2020 | 840 | 0.290 |
Why?
| | Germ-Free Life | 4 | 2025 | 33 | 0.280 |
Why?
| | Receptors, Complement 3b | 1 | 2008 | 79 | 0.270 |
Why?
| | HLA-B27 Antigen | 2 | 2024 | 16 | 0.260 |
Why?
| | Biomarkers | 4 | 2024 | 4351 | 0.260 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 6041 | 0.250 |
Why?
| | Cell Proliferation | 1 | 2014 | 2529 | 0.250 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1514 | 0.250 |
Why?
| | Feces | 4 | 2025 | 500 | 0.240 |
Why?
| | Bacterial Translocation | 1 | 2025 | 52 | 0.220 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.220 |
Why?
| | Symbiosis | 2 | 2017 | 73 | 0.220 |
Why?
| | Tea | 1 | 2025 | 17 | 0.220 |
Why?
| | Arthritis, Psoriatic | 1 | 2024 | 15 | 0.210 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2015 | 69 | 0.210 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 39 | 0.210 |
Why?
| | Hexanols | 1 | 2024 | 7 | 0.210 |
Why?
| | Methylamines | 1 | 2024 | 39 | 0.210 |
Why?
| | Peptides, Cyclic | 1 | 2006 | 273 | 0.210 |
Why?
| | Fingolimod Hydrochloride | 1 | 2024 | 40 | 0.200 |
Why?
| | Ileitis | 1 | 2023 | 33 | 0.200 |
Why?
| | B-Lymphocytes | 2 | 2025 | 878 | 0.200 |
Why?
| | Choline | 1 | 2024 | 138 | 0.190 |
Why?
| | Congresses as Topic | 1 | 2024 | 226 | 0.190 |
Why?
| | Colitis, Ulcerative | 1 | 2025 | 149 | 0.190 |
Why?
| | Bifidobacterium longum | 1 | 2022 | 6 | 0.180 |
Why?
| | Autoantigens | 2 | 2022 | 429 | 0.180 |
Why?
| | Disease Susceptibility | 2 | 2021 | 347 | 0.180 |
Why?
| | Mucous Membrane | 2 | 2024 | 130 | 0.180 |
Why?
| | Oryza | 1 | 2022 | 33 | 0.180 |
Why?
| | Erythema Nodosum | 1 | 2022 | 6 | 0.180 |
Why?
| | Pyoderma Gangrenosum | 1 | 2022 | 8 | 0.180 |
Why?
| | Case-Control Studies | 2 | 2021 | 3660 | 0.170 |
Why?
| | Granzymes | 1 | 2021 | 50 | 0.160 |
Why?
| | Risk Factors | 6 | 2025 | 11017 | 0.160 |
Why?
| | Uveitis | 1 | 2022 | 151 | 0.160 |
Why?
| | Mentors | 1 | 2022 | 218 | 0.160 |
Why?
| | United States | 5 | 2025 | 16313 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 175 | 0.150 |
Why?
| | Cell Differentiation | 2 | 2024 | 2054 | 0.150 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 193 | 0.150 |
Why?
| | Bacteroides | 2 | 2019 | 20 | 0.150 |
Why?
| | Glucose Intolerance | 1 | 2021 | 142 | 0.150 |
Why?
| | Bacteriophages | 1 | 2021 | 110 | 0.150 |
Why?
| | Male | 19 | 2025 | 73950 | 0.140 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 60 | 0.140 |
Why?
| | Disease | 1 | 2019 | 96 | 0.140 |
Why?
| | Adaptive Immunity | 1 | 2020 | 171 | 0.140 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 337 | 0.140 |
Why?
| | Homeodomain Proteins | 1 | 2022 | 525 | 0.140 |
Why?
| | Epithelial Cells | 2 | 2015 | 1141 | 0.140 |
Why?
| | Mice, Transgenic | 2 | 2022 | 2197 | 0.140 |
Why?
| | Lymphocytes | 1 | 2020 | 378 | 0.140 |
Why?
| | Immunoglobulin G | 1 | 2022 | 901 | 0.140 |
Why?
| | Immune System | 1 | 2019 | 181 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2021 | 252 | 0.130 |
Why?
| | Monocytes | 1 | 2020 | 539 | 0.130 |
Why?
| | HIV | 1 | 2019 | 251 | 0.130 |
Why?
| | Disease Progression | 1 | 2025 | 2890 | 0.130 |
Why?
| | Immune Tolerance | 1 | 2020 | 386 | 0.130 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 89 | 0.130 |
Why?
| | Homosexuality, Male | 1 | 2019 | 234 | 0.130 |
Why?
| | Female | 18 | 2025 | 80076 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 569 | 0.120 |
Why?
| | Antibody Formation | 2 | 2008 | 288 | 0.120 |
Why?
| | Pilot Projects | 1 | 2022 | 1912 | 0.120 |
Why?
| | Computational Biology | 1 | 2021 | 677 | 0.120 |
Why?
| | Obesity | 2 | 2021 | 3149 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 266 | 0.110 |
Why?
| | Sulfatases | 1 | 2015 | 5 | 0.110 |
Why?
| | Secretory Vesicles | 1 | 2015 | 24 | 0.110 |
Why?
| | Claudin-1 | 1 | 2015 | 17 | 0.110 |
Why?
| | Histones | 1 | 2020 | 672 | 0.110 |
Why?
| | Tight Junctions | 1 | 2015 | 86 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2014 | 36 | 0.110 |
Why?
| | Antigens, Bacterial | 1 | 2015 | 126 | 0.100 |
Why?
| | Middle Aged | 12 | 2025 | 36821 | 0.100 |
Why?
| | Adult | 12 | 2025 | 41405 | 0.100 |
Why?
| | Autoimmunity | 3 | 2020 | 935 | 0.100 |
Why?
| | Software | 1 | 2019 | 683 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1720 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1794 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1518 | 0.100 |
Why?
| | Homeostasis | 1 | 2017 | 651 | 0.100 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1496 | 0.090 |
Why?
| | Rheumatologists | 2 | 2023 | 15 | 0.090 |
Why?
| | Physicians | 1 | 2021 | 961 | 0.090 |
Why?
| | Asthma | 1 | 2024 | 1805 | 0.090 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 366 | 0.090 |
Why?
| | Wound Healing | 1 | 2014 | 361 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1940 | 0.080 |
Why?
| | Biopsy | 1 | 2014 | 1093 | 0.080 |
Why?
| | Citrulline | 2 | 2008 | 45 | 0.080 |
Why?
| | Cohort Studies | 4 | 2025 | 6099 | 0.080 |
Why?
| | Carcinogenesis | 2 | 2022 | 230 | 0.080 |
Why?
| | Rheumatoid Factor | 2 | 2008 | 178 | 0.070 |
Why?
| | Porphyromonas gingivalis | 1 | 2008 | 23 | 0.070 |
Why?
| | Freund's Adjuvant | 1 | 2008 | 18 | 0.070 |
Why?
| | Periodontitis | 1 | 2008 | 55 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2008 | 148 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2025 | 6011 | 0.070 |
Why?
| | Joints | 1 | 2008 | 106 | 0.060 |
Why?
| | Complement C3 | 1 | 2008 | 188 | 0.060 |
Why?
| | Immunoglobulin Isotypes | 1 | 2006 | 36 | 0.060 |
Why?
| | HIV Infections | 2 | 2019 | 3235 | 0.060 |
Why?
| | Lupus Vulgaris | 1 | 2006 | 4 | 0.060 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 49 | 0.060 |
Why?
| | Immunization | 1 | 2008 | 375 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2454 | 0.060 |
Why?
| | Antibody Specificity | 1 | 2006 | 180 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2625 | 0.060 |
Why?
| | Fibrinogen | 1 | 2006 | 180 | 0.050 |
Why?
| | Synovial Membrane | 1 | 2006 | 128 | 0.050 |
Why?
| | Child | 1 | 2025 | 22979 | 0.050 |
Why?
| | Paneth Cells | 1 | 2023 | 20 | 0.050 |
Why?
| | Cattle | 1 | 2006 | 948 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 191 | 0.050 |
Why?
| | Cholelithiasis | 2 | 1992 | 36 | 0.050 |
Why?
| | Azoxymethane | 1 | 2022 | 18 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2022 | 93 | 0.040 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 9 | 0.040 |
Why?
| | Lactobacillus | 1 | 2022 | 28 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 6164 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 61 | 0.040 |
Why?
| | Acetylglucosamine | 1 | 2001 | 14 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 101 | 0.040 |
Why?
| | Citrullination | 1 | 2020 | 12 | 0.040 |
Why?
| | Quality of Life | 2 | 2025 | 3246 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 708 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 506 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2001 | 440 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 219 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2022 | 340 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 365 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 476 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 325 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2025 | 1162 | 0.040 |
Why?
| | Chondrocytes | 1 | 2001 | 232 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2136 | 0.030 |
Why?
| | Buspirone | 1 | 1998 | 5 | 0.030 |
Why?
| | Aged | 5 | 2021 | 26514 | 0.030 |
Why?
| | Serotonin Receptor Agonists | 1 | 1998 | 27 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2001 | 786 | 0.030 |
Why?
| | Lorazepam | 1 | 1998 | 26 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2001 | 481 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 88 | 0.030 |
Why?
| | Organ Specificity | 1 | 2018 | 310 | 0.030 |
Why?
| | Anti-Anxiety Agents | 1 | 1998 | 48 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 507 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2019 | 320 | 0.030 |
Why?
| | Smoking | 1 | 2025 | 1483 | 0.030 |
Why?
| | Prevalence | 1 | 2025 | 2889 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2001 | 481 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 163 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1049 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 254 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2001 | 961 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3372 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 924 | 0.030 |
Why?
| | Procollagen | 1 | 1976 | 24 | 0.030 |
Why?
| | Time Factors | 2 | 2006 | 7173 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 1000 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 139 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2015 | 152 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2019 | 502 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 1998 | 376 | 0.030 |
Why?
| | Diet | 1 | 2022 | 1284 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 377 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 533 | 0.020 |
Why?
| | Qualitative Research | 1 | 2021 | 1735 | 0.020 |
Why?
| | Gene Deletion | 1 | 2015 | 392 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 372 | 0.020 |
Why?
| | Cell Line | 2 | 2015 | 2832 | 0.020 |
Why?
| | Gallbladder Emptying | 1 | 1992 | 1 | 0.020 |
Why?
| | Gallbladder | 1 | 1992 | 15 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2022 | 5476 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 774 | 0.020 |
Why?
| | Lithotripsy | 1 | 1992 | 49 | 0.020 |
Why?
| | Cholecystectomy | 1 | 1992 | 61 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2015 | 721 | 0.020 |
Why?
| | Fibroblasts | 1 | 1976 | 1039 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1253 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 1992 | 258 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1916 | 0.020 |
Why?
| | Atenolol | 1 | 1988 | 8 | 0.020 |
Why?
| | Luteal Phase | 1 | 1988 | 51 | 0.020 |
Why?
| | Premenstrual Syndrome | 1 | 1988 | 33 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2008 | 163 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5272 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 14437 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2007 | 131 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 2008 | 430 | 0.010 |
Why?
| | Pregnancy | 1 | 2018 | 7274 | 0.010 |
Why?
| | Depressive Disorder | 1 | 1988 | 379 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 800 | 0.010 |
Why?
| | Infant | 1 | 2018 | 10194 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2007 | 1140 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2001 | 57 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 2017 | 0.010 |
Why?
| | Acetylgalactosamine | 1 | 2001 | 2 | 0.010 |
Why?
| | Glucosamine | 1 | 2001 | 14 | 0.010 |
Why?
| | Cyclooxygenase 1 | 1 | 2001 | 27 | 0.010 |
Why?
| | Interleukin-12 | 1 | 2001 | 115 | 0.010 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 76 | 0.010 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2001 | 117 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 153 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2001 | 162 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 2001 | 167 | 0.010 |
Why?
| | Peptides | 1 | 2006 | 1003 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 234 | 0.010 |
Why?
| | Isoenzymes | 1 | 2001 | 296 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 264 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2001 | 288 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 762 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 22825 | 0.010 |
Why?
| | Double-Blind Method | 2 | 1998 | 2080 | 0.010 |
Why?
| | Manifest Anxiety Scale | 1 | 1998 | 3 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 1371 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2001 | 589 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2001 | 2030 | 0.010 |
Why?
| | NF-kappa B | 1 | 2001 | 676 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 2001 | 349 | 0.010 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 1976 | 16 | 0.010 |
Why?
| | Phosphorylation | 1 | 2001 | 1721 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2001 | 892 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 1976 | 184 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2001 | 1171 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4169 | 0.010 |
Why?
| | Chenodeoxycholic Acid | 1 | 1992 | 12 | 0.010 |
Why?
| | Ursodeoxycholic Acid | 1 | 1992 | 17 | 0.010 |
Why?
| | Food | 1 | 1992 | 150 | 0.010 |
Why?
| | Fasting | 1 | 1992 | 280 | 0.010 |
Why?
| | Odds Ratio | 1 | 1992 | 1084 | 0.000 |
Why?
| | Renin | 1 | 1988 | 33 | 0.000 |
Why?
| | Aldosterone | 1 | 1988 | 42 | 0.000 |
Why?
| | Ultrasonography | 1 | 1992 | 795 | 0.000 |
Why?
| | Random Allocation | 1 | 1988 | 366 | 0.000 |
Why?
| | Progesterone | 1 | 1988 | 215 | 0.000 |
Why?
| | Estrogens | 1 | 1988 | 368 | 0.000 |
Why?
| | Incidence | 1 | 1992 | 2954 | 0.000 |
Why?
| | Clinical Trials as Topic | 1 | 1988 | 1072 | 0.000 |
Why?
| | Treatment Outcome | 1 | 1998 | 11947 | 0.000 |
Why?
| | Prospective Studies | 1 | 1992 | 8164 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1992 | 17560 | 0.000 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|